An interventional study of Auriculotherapy for chronic pain treatment with laser stimulation of acupoints using red light and "Auriculotherapy for chronic pain treatment with stimulation of acupoints using mustard seeds." in Chronic Knee Pain, Chronic Shoulder Pain and Chronic Low Back Pain, sponsored by Universidade do Vale do Paraíba. Completed at 1 site in Brazil. Open to participants aged 60 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-10-06.
Sponsored by Universidade do Vale do Paraíba · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 67 studies in Chronic Pain with a site in Brazil — 10 open to participants now, 12 under way, none of them phase 3. Chronic Pain · Brazil.
Among the 67 studies in Chronic Pain with a site in Brazil, this one is the 29th largest by enrollment of the 61 interventional ones that give a count, is one of 7 that started in 2025, is one of 48 with no phase, and was the 62nd registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →10 of the 67 studies in Chronic Pain with a site in Brazil are open now. Recruiting first, the newest first:
Universidade Federal do Rio Grande do Norte · Sites in Brazil
Ages 18–65 · Women only
Federal University of Bahia · Sites in Brazil
Ages 18–55
Universidade Federal do Rio Grande do Norte · Sites in Brazil
Ages 20–69
University of Sao Paulo General Hospital · Sites in Brazil
Ages 18+
University of Nove de Julho · Sites in Brazil
Ages 18–50
A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 60 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
67 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 7 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 60 is close to the median of 60 across 2,388 interventional studies indexed under Chronic Pain.
Median enrollment 60 across the 61 interventional studies, 308 across the 5 observational. Of the 37 that completed or were terminated, 3 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 67 have an industry lead sponsor. The 10 most frequent:
Universidade do Vale do Paraíba is the lead sponsor of 17 studies on the registry; none are open to participants now.
Universidade do Vale do Paraíba has 1 study filed under Chronic Pain — fewer than ten, so there is no comparison to draw.
1 of the studies in Chronic Pain with a site in Brazil that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07783295Associação Pan-Americana Multidisciplinar de EndocanabinologiaFull-Spectrum Cannabis Extract for Chronic Pain and Bone Health Biomarkers in Women | 2027-09-01 |
Add it to your calendar (.ics) → With an account.
Among the 67 studies in Chronic Pain with a site in Brazil, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The objective of the study is to evaluate the effectiveness of a treatment protocol using auricular acupuncture point stimulation with laser, compared with the use of mustard seeds, for reducing chronic pain in older adults. With this research, the researchers hope to obtain results that will allow the establishment of a non-invasive, easy-to-apply, and painless treatment protocol to minimize chronic pain in the lumbar spine, shoulders, and knees, thereby improving the quality of life of the target population. At the first session, before the start of the treatment protocol, three questionnaires will be administered: the SF-36 to assess quality of life, the Visual Analog Scale for pain intensity, and the McGill Pain Questionnaire. The pain region will also be assessed using a thermographic camera to evaluate skin temperature and the Ryodoraku System. The same evaluation protocol will be repeated before the fifth session and after the tenth session.
This study analyzed the effectiveness of treatment protocols A and B for chronic pain in the shoulder, knee, or lumbar spine regions in older adults. Protocol A involved the application of low-power red laser therapy to auriculotherapy acupoints. Protocol B involved the application of mustard seeds. To assess the qualitative aspect of the study, the McGill Pain Questionnaire and the Visual Analog Scale were used to evaluate chronic pain, while the SF-36 instrument assessed the participants' quality of life before and after the treatment protocol. For the quantitative evaluation, thermographic imaging and the Ryodoraku System were used. All proposed tools were applied before the first treatment session, before the fifth session, and at the end of the tenth session.
Risks and Benefits
During the study, participants were subject to risks related to physical and psychological discomfort due to the proposed therapeutic protocol. All procedures were performed individually in an appropriate and private room to ensure the participants' comfort and privacy. Each participant was provided with protective goggles, which were worn throughout the laser application period. These goggles were sanitized before each session, and the laser device tip was covered with PVC film, which was replaced after each session.
Although rare, stimulation of the auricular pavilion could cause transient side effects such as local pain, fatigue, dizziness, nausea, and headaches. The use of the laser could generate slight discomfort, such as mild warming, but this effect was temporary and had no serious consequences. If a participant experienced any of these symptoms or any other physical discomfort, the protocol was immediately interrupted, and the participant remained under observation by the researcher until they felt better. The use of mustard seeds could cause mild pain at the application site, but this typically subsided over time. Participants were informed that if a seed fell off prematurely, it would not affect the treatment, and they should continue stimulating the remaining seeds three times a day and remove them one day before the next session.
Psychological discomfort could also arise when participants answered the questionnaires. The questionnaires were administered in a private setting with only the participant and the researcher present. If the participant felt uncomfortable, they could request to withdraw from the study.
To minimize the risk of exposure of participants' personal data, the researcher committed to storing all collected data in password-protected digital files accessible only to the research team. Each participant was assigned an individual identification code to prevent any possibility of unauthorized access or identification.
Whenever the participant wished, the principal researcher provided clarifications regarding the procedures to establish trust. Participants were informed that they could withdraw from the study at any time without affecting the continuity of their treatment.
As a benefit of this study, the results were expected to help establish a non-invasive, easy-to-apply, and ergonomically comfortable treatment protocol for chronic pain in older adults, thereby improving their quality of life.
Clinical Protocol
The participants were received individually in a private room with only the researcher present. They were instructed to sit comfortably in a chair. The McGill Pain Questionnaire, the SF-36 questionnaire, and the Visual Analog Scale for Pain were then administered to assess pain intensity and its impact on the participants' quality of life.
After completing the questionnaires, while still seated, the researcher evaluated the participants using the Ryodoraku System for bioenergetic meridian measurement. This assessment was conducted through 24 reactive points, known as electro-permeable skin points, located on the upper and lower limbs at the acupoints P9, PC7, C7, ID5, TA4, IG5, BP3, F3, R4, B65, VB40, and E42. The Ryodoraku System is a portable electronic device equipped with two wand-shaped electrodes. One wand was held by the participant, while the researcher manipulated the other, placing it in direct contact with the acupoints. The device was connected via USB to a computer with pre-installed software, generating graphs that compared the participants' meridian conditions and possible energy imbalances with a standard balanced energy pattern.
Next, thermographic images of the area where the participant experienced chronic pain were taken using a thermal imaging camera. During this process, participants stood upright on an insulated rubber surface. The analyzed region was free of clothing. Images were captured from a distance of 50 cm from the target area to ensure proper framing, against a black background to avoid infrared radiation reflection. Participants were instructed to avoid alcohol, physical exercise, bathing, and stimulant intake (such as caffeine) for at least two hours before the examination.
The evaluation tools for research data collection were applied before the first session, before the fifth session, and after the tenth session.
Treatment Protocol
For participants in Group A (GA), a portable Recover® laser device (MM Optics) was used. The device was operated with red laser light at a wavelength of 660 nm, an output power of 100 mW, a beam area of 0.03 cm², and continuous emission. An energy of 4 J was delivered to each auricular point over 40 seconds per point. All participants sat in a comfortable position and wore protective goggles provided by the researcher, who also wore protective goggles during laser application.
For participants in Group B, mustard seeds were applied with micropore tape to the same auriculotherapy acupoints used in Group A. Each participant underwent ten sessions, twice a week, over five weeks of treatment.
For participants with shoulder or knee pain, the auriculotherapy acupoints were treated on the ear corresponding to the side of the reported pain. For participants with low back pain, the right ear was treated. These points were previously cleaned with gauze soaked in 70% alcohol. Additionally, the laser device tip was wrapped in PVC film, which was replaced for each participant.
The criteria were revised on the registry on Oct 6, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Stimulation using a laser operating in continuous mode, with red light at a wavelength of 660 nm, an output power of 100 mW, and a beam area of 0.03 cm². An energy of 4 J was delivered to each auricular acupoint over 40 seconds per point: 1. Chronic shoulder pain: Shen Men, Kidneys, Peripheral Nervous System, Analgesia, Muscle Relaxation, Shoulder Region, Adrenal; 2. Chronic knee pain: Shen Men, Kidneys, Peripheral Nervous System, Analgesia, Muscle Relaxation, Knee Region, Adrenal; 3. Chronic lumbar pain: Shen Men, Kidneys, Peripheral Nervous System, Analgesia, Muscle Relaxation, Lumbar Region, Adrenal.
Procedure: Auriculotherapy for chronic pain treatment with laser stimulation of acupoints using red light
The conventional clinical practice treatment was carried out using mustard seeds to stimulate the following auricular acupoints: 1. Chronic shoulder pain: Shen Men, Kidneys, Peripheral Nervous System, Analgesia, Muscle Relaxation, Shoulder Region, Adrenal; 2. Chronic knee pain: Shen Men, Kidneys, Peripheral Nervous System, Analgesia, Muscle Relaxation, Knee Region, Adrenal; 3. Chronic lumbar pain: Shen Men, Kidneys, Peripheral Nervous System, Analgesia, Muscle Relaxation, Lumbar Region, Adrenal. Participants were instructed to press the seeds three times a day and to remove them one day before the next treatment session.
Procedure: "Auriculotherapy for chronic pain treatment with stimulation of acupoints using mustard seeds."
This arm of the study analyzed the effectiveness of the treatment protocol for chronic pain in the shoulder, knee, or lumbar spine regions in older adults, using auricular acupuncture with low-power red laser stimulation applied to auriculotherapy acupoints. For the qualitative evaluation of the study, the McGill Pain Questionnaire (Annex A) and the Visual Analog Scale (Annex B) were used to assess chronic pain, while the SF-36 instrument (Annex C) was used to assess participants' quality of life before and after the treatment protocol. For the quantitative evaluation, thermographic imaging and the Ryodoraku System were used. All proposed assessment tools were applied before the first treatment session (A1), before the fifth session (A2), and after the tenth session (A3).
This arm of the study analyzed the effectiveness of the treatment protocol for chronic pain in the shoulder, knee, or lumbar spine regions in older adults, using mustard seeds applied to auriculotherapy acupoints. For the qualitative evaluation of the study, the McGill Pain Questionnaire (Annex A) and the Visual Analog Scale (Annex B) were used to assess chronic pain, while the SF-36 instrument (Annex C) was used to assess participants' quality of life before and after the treatment protocol. For the quantitative evaluation, thermographic imaging and the Ryodoraku System were used. All proposed assessment tools were applied before the first treatment session (A1), before the fifth session (A2), and after the tenth session (A3).
Comparative efficacy evaluation between the application of auricular laser acupuncture and the use of mustard seeds in the treatment of chronic pain
Data were analyzed using linear mixed-effects models. Each outcome was modeled as a function of MOMENT (A1, A2, and A3), GROUP (Laser and Seed), and the MOMENT × GROUP interaction, with a random intercept for participant. Models were estimated using restricted maximum likelihood (REML), with Satterthwaite approximation for degrees of freedom. Statistical significance was set at p \< 0.05. When significant omnibus effects were identified, estimated marginal means were compared using Bonferroni-adjusted post hoc tests.
Time frame: From baseline (before the first treatment session) to the end of treatment after the tenth session, approximately 5 weeks.
Plan to share: Yes — Description of the IPD to be Shared: All individual participant data (IPD) collected during the study, including de-identified demographic data, clinical outcomes (pain scores, quality of life assessments), Ryodoraku measurements, and thermographic imaging data. What data will be shared: All IPD underlying the results of the published primary and secondary outcome measures.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report
Time frame: When will the data be available: 6 months after the publication of the main results. How long will the data be available: The data will be available for 5 years after the initial publication.
Access criteria: Qualified researchers who submit a methodologically sound proposal for secondary analyses.
No publications or documents are linked to this record.
Ran from May 2025 to primary completion in Dec 2025, 6 months.
Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's 6 months is below that.
Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidade do Vale do Paraíba